Why PCPs Miss PMADs: Brief Visits, Limited Training, and Patient Minimization

Detection rates for perinatal mood and anxiety disorders in unscreened primary care panels run between 30 and 50 percent of true cases. The gap is not a question of clinician attention or competence. It is structural, and understanding the specific barriers helps PCPs close it efficiently.

Barrier 1: The 15-minute visit architecture

Primary care visits are built around acute complaints, chronic disease metrics, and preventive care prompts. A typical postpartum patient arrives with infant feeding questions, contraception decisions, weight concerns, and a thyroid recheck queued. Mental health screening, even when on the agenda, competes with billable problems that have firmer clinical workflows.

The result is predictable. Mood and anxiety questions move to the bottom of the visit, often surfacing in the last 60 seconds when the patient is already standing. Disclosure at that moment is rare.

Barrier 2: Limited perinatal-specific training

Most family medicine residency curricula touch on postpartum depression briefly within behavioral health rotations. Internal medicine programs typically do not address it at all. The clinical knowledge gaps that result include:

• Differentiating postpartum blues (peaks day 3 to 5, resolves by week 2) from postpartum depression (onset within 12 months, persistent)
• Recognizing postpartum psychosis as a psychiatric emergency requiring same-day evaluation
• Understanding perinatal anxiety, OCD, and PTSD as distinct entities with different treatment implications
• Prescribing SSRIs during pregnancy and lactation with up-to-date risk-benefit framing
• Identifying intrusive thoughts in postpartum OCD versus harm ideation in psychosis

PCPs trained only in adult depression frameworks often default to generic SSRI initiation or refer broadly to therapy without distinguishing presentation. This reduces both diagnostic accuracy and patient confidence.

Barrier 3: Somatic masking

PMADs present somatically more often than they present with explicit mood complaints. The most common chief complaints concealing a PMAD:

• Insomnia, particularly insomnia that persists when the infant is sleeping
• Fatigue exceeding the expected postpartum recovery curve
• New GI symptoms including nausea, reflux, or altered bowel habits
• Headache, often described as new in character
• Palpitations, chest tightness, or shortness of breath without cardiac etiology
• Diffuse pain or musculoskeletal complaints

These presentations route patients into endocrine, cardiac, or GI workups. The labs come back normal, the patient is reassured, and the underlying anxiety or depression remains uncoded.

Barrier 4: Patient-side minimization and stigma

Perinatal patients underreport mental health symptoms at rates higher than the general adult population. The drivers are well documented:

• Fear of CPS involvement or custody implications
• Concern that disclosure will be recorded permanently in the medical record
• Internalized expectation that struggle equals maternal failure
• Cultural messages framing postpartum hardship as normal and not medical
• Limited rapport with a clinician they may have met only once or twice

Even when asked directly, many patients answer "I'm fine" until the question is structured, anonymous-feeling, and on paper. This is precisely why validated written screeners outperform open-ended clinical questions.

Barrier 5: Absent referral pathway

A subtle but consequential barrier is the clinician's own awareness of where to send a positive screen. PCPs who lack a known specialist referral pathway often delay screening unconsciously, because identifying a problem they cannot solve creates a workflow dead end. Practices that establish a perinatal mental health referral relationship in advance screen at higher rates and report greater clinician confidence.

Barrier 6: EHR and documentation friction

A frequently overlooked structural barrier is the EHR itself. In many primary care builds, mental health screeners are buried under behavioral health templates, scoring is not automated, and structured fields for EPDS or GAD-7 results do not exist. Clinicians who want to screen end up entering scores in free-text notes, which prevents tracking, prevents quality reporting, and makes population-level audits impossible.

The downstream effect is that screening feels like extra documentation work without any institutional payoff. Practices that build a structured EPDS field, attach it to the postpartum visit type, and surface positive scores in the rooming workflow remove this friction and see screening rates climb without additional clinician effort.

Closing the gap

Each barrier has a practical counterweight:

• Workflow: administer EPDS or PHQ-9 before the visit via tablet or portal so scoring is ready when the clinician enters the room
• Training: build a one-page internal reference covering postpartum blues vs. PPD vs. psychosis, SSRI lactation guidance, and red flags
• Somatic masking: add EPDS to any postpartum visit presenting with insomnia, fatigue, or unexplained somatic complaint
• Stigma: frame screening as routine, like blood pressure, and document non-stigmatizing language in the chart
• Referral pathway: identify a perinatal mental health specialist or telehealth partner before you need one
• EHR: build a structured score field, attach it to defined visit types, and route positive screens through the rooming workflow

Comorbidity recognition as a multiplier

A separate detection gap exists within the PMAD cases that are identified. PCPs who catch postpartum depression may not recognize that the same patient also meets criteria for a comorbid anxiety disorder, which affects up to half of patients with perinatal depression. Treating depression alone without addressing comorbid anxiety produces slower resolution and higher relapse rates.

The practical implication: using a depression-focused screener like the PHQ-9 as the only tool misses pure anxiety presentations entirely and understates symptom burden in comorbid presentations. The EPDS anxiety subscale (items 3, 4, 5) and a brief GAD-7 add fewer than five minutes to the pre-visit intake and close this gap. Practices that switch to dual screening, depression and anxiety, routinely find that their documented PMAD case count rises by 25 to 40 percent within the first year, not because prevalence changed, but because the tool was finally matching the clinical reality.

A related pattern: patients with prior OCD who have a postpartum relapse are frequently coded as postpartum depression because the intrusive thought content is misread as suicidal ideation. Asking one clarifying question, whether the thoughts feel like the patient's own thinking or like something imposed or alien, routes the clinical encounter appropriately.

Briefing the care team

Closing the detection gap is rarely a solo clinician project. The MAs, front desk, nurses, and behavioral health staff who interact with perinatal patients before and after the clinical encounter need a shared baseline. A 30-minute team huddle before launching screening should cover: which visit types trigger the EPDS, how to administer it without coaching the answers, what to do if a patient declines, how to route a positive item 10 response, and the script for warm handoffs to the referral partner. Practices that brief their staff this way consistently outperform practices that launch screening as a clinician-only initiative.

PCPs miss PMADs not because they are inattentive, but because the visit, the training pipeline, and the patient experience are aligned against detection. Structured screening and a defined referral pathway flip those defaults.